Neuberger Berman Group
TEVA icon

Neuberger Berman Group’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$662K Buy
39,514
+12,158
+44% +$204K ﹤0.01% 1493
2025
Q1
$420K Sell
27,356
-2,042
-7% -$31.4K ﹤0.01% 1569
2024
Q4
$648K Sell
29,398
-3,884,672
-99% -$85.6M ﹤0.01% 1446
2024
Q3
$70.5M Buy
3,914,070
+24,081
+0.6% +$434K 0.06% 372
2024
Q2
$63.2M Sell
3,889,989
-139,727
-3% -$2.27M 0.05% 372
2024
Q1
$56.9M Buy
4,029,716
+4,004,205
+15,696% +$56.5M 0.05% 407
2023
Q4
$266K Buy
25,511
+9,534
+60% +$99.5K ﹤0.01% 1684
2023
Q3
$163K Buy
+15,977
New +$163K ﹤0.01% 1714
2020
Q3
Sell
-1,718,494
Closed -$21.2M 1657
2020
Q2
$21.2M Buy
1,718,494
+140,933
+9% +$1.74M 0.03% 555
2020
Q1
$14.2M Buy
+1,577,561
New +$14.2M 0.02% 577
2019
Q3
Sell
-37,238
Closed -$344K 1587
2019
Q2
$344K Sell
37,238
-581,014
-94% -$5.37M ﹤0.01% 1360
2019
Q1
$9.69M Buy
618,252
+24,591
+4% +$386K 0.01% 748
2018
Q4
$9.15M Sell
593,661
-4,186
-0.7% -$64.5K 0.01% 746
2018
Q3
$12.9M Sell
597,847
-9
-0% -$194 0.01% 747
2018
Q2
$14.5M Buy
597,856
+2,027
+0.3% +$49.3K 0.02% 729
2018
Q1
$10.2M Buy
595,829
+1,092
+0.2% +$18.7K 0.01% 776
2017
Q4
$11.3M Sell
594,737
-93,804
-14% -$1.78M 0.01% 756
2017
Q3
$12.1M Sell
688,541
-176,208
-20% -$3.1M 0.02% 715
2017
Q2
$28.7M Buy
864,749
+60,853
+8% +$2.02M 0.04% 518
2017
Q1
$25.8M Sell
803,896
-1,750,432
-69% -$56.2M 0.03% 537
2016
Q4
$92.6M Sell
2,554,328
-1,829,529
-42% -$66.3M 0.12% 249
2016
Q3
$202M Sell
4,383,857
-1,664,770
-28% -$76.6M 0.27% 96
2016
Q2
$304M Buy
6,048,627
+817,492
+16% +$41.1M 0.42% 47
2016
Q1
$280M Buy
5,231,135
+1,805,157
+53% +$96.6M 0.38% 62
2015
Q4
$225M Sell
3,425,978
-197,588
-5% -$13M 0.29% 93
2015
Q3
$205M Sell
3,623,566
-2,472,633
-41% -$140M 0.26% 110
2015
Q2
$360M Sell
6,096,199
-509,959
-8% -$30.1M 0.4% 48
2015
Q1
$412M Buy
6,606,158
+483,048
+8% +$30.1M 0.44% 43
2014
Q4
$352M Buy
6,123,110
+3,503,300
+134% +$201M 0.37% 60
2014
Q3
$141M Sell
2,619,810
-76,852
-3% -$4.13M 0.14% 200
2014
Q2
$141M Buy
2,696,662
+840,745
+45% +$44.1M 0.14% 210
2014
Q1
$98.1M Buy
1,855,917
+1,410,625
+317% +$74.5M 0.1% 300
2013
Q4
$17.8M Buy
445,292
+75,151
+20% +$3.01M 0.02% 672
2013
Q3
$14M Buy
370,141
+549
+0.1% +$20.7K 0.02% 715
2013
Q2
$14.5M Buy
+369,592
New +$14.5M 0.02% 679